Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

复方氢氧化铝片 - NMPA Drug Approval Details

Approvals/NMPA/Compound Aluminium Hydroxide Tablets

Approved

化学药品

Compound Aluminium Hydroxide Tablets

河北利鑫制药有限公司🇨🇳 National Medical Products Administration

Approval Date: Aug 16, 2020
Approval ID: 7LeaeLP1a98
Company: 河北利鑫制药有限公司
Type: 化学药品

Approval Details

Approval Id: 7LeaeLP1a98
Approval Number: 国药准字H13020722
Generic Name: 复方氢氧化铝片
Generic Name En: Compound Aluminium Hydroxide Tablets
Drug Type: 化学药品
Dosage Form: 片剂
Strength: 氢氧化铝0.245g,三硅酸镁0.105g
Reg Date: 2020-08-16
Company Name: 河北利鑫制药有限公司
Company Address: 石家庄市鹿泉区黄壁庄镇
Company Detail Path: /organization/he-bei-li-xin-zhi-yao-you-xian-gong-si

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Aug 16, 2020

Approval ID

7LeaeLP1a98

Type

化学药品

Back to NMPA Approvals